Advisors Preferred’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Advisors Preferred's CRL Position: Q1 2022 in Review
Advisors Preferred sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 3,926 shares — an estimated $1.42M sold.
Advisors Preferred first reported a position in CRL in Q1 2014 and held it in 2 quarters. The position peaked at $1.42M in Q4 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.
- Advisors Preferred reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
- Advisors Preferred sold 3,926 Charles River Laboratories shares in Q1 2022, an estimated $1.42M.
- Advisors Preferred first reported a position in Charles River Laboratories in Q1 2014 and held it in 2 quarters.
- Advisors Preferred's Charles River Laboratories position peaked at $1.42M in Q4 2021.
- 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.
Based on Advisors Preferred's 13F filing for Q1 2022, filed 9 May 2022.